Medial Patellofemoral Ligament Reconstruction vs Nonoperative Treatment for Recurrent Lateral Patellar Dislocation: Three-Year Results From a Randomized Controlled Trial

医学 随机对照试验 髌股内侧韧带 外科 髌骨 骨关节炎 内侧副韧带 下肢 关节置换术 腿筋拉伤
作者
Truls Martin Straume-Næsheim,Per-Henrik Randsborg,Tina Løkken Nilsgård,Asbjørn Årøen
出处
期刊:American Journal of Sports Medicine [SAGE Publishing]
卷期号:54 (4): 773-779
标识
DOI:10.1177/03635465261416931
摘要

Background: Medial patellofemoral ligament reconstruction (MPFL-R) is the primary surgical intervention for recurrent lateral patellar dislocation (LPD). Isolated MPFL-R is recommended for patients without anatomic high-risk factors that predispose to further dislocations. Purpose: To compare instability recurrence in patients with recurrent LPD without underlying anatomic risk factors treated with MPFL-R versus active rehabilitation. Study Design: Randomized controlled clinical trial; Level of evidence, 1. Methods: Patients aged 12 to 30 years with recurrent LPD and no underlying anatomic high-risk factors for further dislocations—specifically, no severe trochlear dysplasia (Dejour D) and a tibial tuberosity–trochlear groove distance ≤20 mm on computed tomography—were randomized to receive knee arthroscopy with isolated MPFL-R followed by active rehabilitation (MPFL group) or knee arthroscopy without reconstruction followed by active rehabilitation (control group). The primary outcome was subjective persistent patellar instability at 3 years. Knee function at baseline and 1 and 3 years was assessed by the following patient-reported outcome measure (PROM) scores: Knee injury and Osteoarthritis Outcome Score (KOOS), Kujala Knee Score, Cincinnati Knee Rating System, and Noyes Sports Activity Rating Scale. Results: Between 2010 and 2019, 61 patients (72.1% female) were included in the study and randomized, with 30 assigned to the MPFL group and 31 to the control group. At 3-year follow-up, subjective persistent patellar instability was reported by 5 patients in the MPFL group (16.7%) versus 15 patients in the control group (53.6%), corresponding to an odds ratio of 5.8 (95% CI, 1.7-19.4; P = .003). Both groups reported significant improvements in all PROM scores from baseline to 3 years. However, no significant differences in PROM scores were observed between the groups at any follow-up time point. Conclusion: Isolated MPFL-R was more effective than active rehabilitation alone in preventing patellar instability after 3 years. Trial Registration: ClinicalTrials.org (NCT02263807).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
传奇3应助机智毛豆采纳,获得10
1秒前
1秒前
万能图书馆应助Bigwang采纳,获得10
1秒前
2秒前
已歌发布了新的文献求助10
2秒前
2秒前
缓慢的刺猬完成签到,获得积分20
2秒前
搞怪如豹完成签到,获得积分10
3秒前
cui发布了新的文献求助10
3秒前
gyh发布了新的文献求助10
3秒前
SciGPT应助xiaobo采纳,获得10
4秒前
陈飞宇发布了新的文献求助10
4秒前
纯真的笑容完成签到,获得积分10
5秒前
李健的粉丝团团长应助17采纳,获得10
5秒前
5秒前
科研通AI6.3应助insane采纳,获得10
5秒前
6秒前
6秒前
SciGPT应助gt采纳,获得20
6秒前
6秒前
7秒前
7秒前
谨慎初曼关注了科研通微信公众号
8秒前
小荷完成签到 ,获得积分10
8秒前
ZN完成签到,获得积分20
8秒前
worldpeace17完成签到,获得积分10
8秒前
cxxx发布了新的文献求助10
8秒前
终生科研徒刑完成签到 ,获得积分10
9秒前
9秒前
9秒前
10秒前
元力完成签到,获得积分10
10秒前
10秒前
10秒前
xx发布了新的文献求助10
11秒前
11秒前
12秒前
哇哈哈哈发布了新的文献求助10
12秒前
爆米花应助cui采纳,获得10
12秒前
13秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7279977
求助须知:如何正确求助?哪些是违规求助? 8901153
关于积分的说明 18827930
捐赠科研通 6952111
什么是DOI,文献DOI怎么找? 3207298
关于科研通互助平台的介绍 2377600
邀请新用户注册赠送积分活动 2182295